On June 4, 2014, LeMaitre Vascular Inc (NASDAQ:LMAT) announced the closing of its previously announced underwritten public offering of 1,644,500 shares of its common stock at a price to the public of $7.00 per share. The shares include 214,500 shares of common stock sold pursuant to the over-allotment option granted by LeMaitre Vascular to the underwriters, which option was exercised in full. LeMaitre Vascular Inc (NASDAQ:LMAT) net profit margin is 3.20% and weekly performance is 11.77%. On last trading day company shares ended up $8.26. Analysts mean target price for the company is $10.70. LeMaitre Vascular Inc (NASDAQ:LMAT) distance from 50-day simple moving average (SMA50) is 7.21%.
On June 23, 2014, AdCare Health Systems, Inc. (NYSEMKT:ADK) announced that, as part of its ongoing rationalization plan, it has signed an agreement to sublease one of its skilled nursing and rehabilitation facilities in South Georgia to a local nursing home operator effective July 1, 2014. AdCare incurred losses of approximately $92,000 in connection with operating this 52-bed facility during the first four months of this year; the facility is now expected to contribute approximately $90,000 of net profits annually during the life of the sublease. AdCare Health Systems, Inc. (NYSEMKT:ADK) shares advanced 4.05% in last trading session and ended the day on $4.37. ADK Gross Margin is 17.00%and its return on assets is -7.70%. AdCare Health Systems, Inc. (NYSEMKT:ADK) quarterly performance is 3.80%.
On June 9, 2014, Sagent Pharmaceuticals Inc (NASDAQ:SGNT), has been ranked seventh on Crain’s 2014 Fast Fifty list, published by Crain’s Chicago Business. This marks the second consecutive year that Sagent has been selected as one of the leading growth companies in Chicago, topping the charts as number one in 2013. The Crain’s Fast Fifty is an annual ranking that features the fastest-growing companies in Chicago. Sagent Pharmaceuticals Inc (NASDAQ:SGNT) shares moved down 3.95% in last trading session and was closed at $25.51, while trading in range of $25.41 – $26.23. Sagent Pharmaceuticals Inc (NASDAQ:SGNT) year to date (YTD) performance is 0.51%.
Heron Therapeutics Inc (NASDAQ:HRTX) announced its intention to offer and sell shares of its common stock in an underwritten offering pursuant to its existing shelf registration. All of the shares in the proposed offering are to be sold by Heron Therapeutics, Inc. Heron Therapeutics Inc (NASDAQ:HRTX) shares moved down -8.85% in last trading session and was closed at $11.64, while trading in range of $11.30 – $11.79. Heron Therapeutics Inc (NASDAQ:HRTX) year to date (YTD) performance is 29.33%.
Ampio Pharmaceuticals, Inc. (NYSE MKT:AMPE) announced that it has informed the Transplant and Ophthalmology Division of the FDA of its intent to reduce the patient sample size in the OptimEyes Study for the treatment of Diabetic Macular Edema (oral treatment with Optina™). This trial was intended to enroll 450 patients and was powered at 95%. The present enrollment of over 355 patients provides an adequate power of 88%, which the company believes is more than sufficient for statistical evaluation. Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) ended the last trading day at $8.08. Company weekly volatility is calculated as 5.45% and price to cash ratio as 5.36. Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) showed a positive weekly performance of 2.28%.